Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets […]
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Josh House as Chief Financial Officer
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, […]
Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, […]
Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration to Advance Innovative Immunotherapies
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets […]
- Kinnate Biopharma Adds Global Business and Oncology Expertise to Board of Directors Read more
- Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication Read more
- New AI Tool Makes Speedy Gene Editing Possible Read more
- European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease Read more
- Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome Read more